Literature DB >> 33423435

Health-Related Quality of Life for Parkinson's Disease Patients and Their Caregivers.

Michal Lubomski1,2,3, Ryan L Davis2, Carolyn M Sue1,2.   

Abstract

Objective: Motor and non-motor symptoms (NMS) negatively impact the health-related quality of life (HRQoL) for individuals with Parkinson's disease (PD), as well as their caregivers. NMS can emerge decades prior to the manifestation of motor symptoms but often go unrecognized and therefore untreated. To guide clinical management, we surveyed differences and identified factors that influence HRQoL in a cohort of PD patients and family caregivers.
Methods: A total of 103 PD patients were compared with 81 caregivers. Outcome measures collected from validated questionnaires included generic and disease-specific HRQoL assessments, depression frequency and severity, constipation severity, upper and lower gastrointestinal symptoms, physical activity and motor symptom severity.
Results: PD patients reported significantly decreased physical and mental HRQoL compared to their caregivers (both p < 0.001). Unemployment, the need for social support services, rehabilitation use, REM sleep behavior disorder, impulse control disorders and features suggestive of increasing disease severity hallmarked by increasing PD duration, higher MDS UPDRS-III (Movement Disorder Society-Unified Parkinson's Disease Rating Scale-Part III) scores, higher daily levodopa equivalence dose and motor fluctuations were consistent with a lower HRQoL in our PD cohort. Furthermore, decreased physical activity, chronic pain, depression, constipation and upper gastrointestinal dysfunction (particularly indigestion, excess fullness and bloating) suggested vulnerability to reduced HRQoL. Overall, PD patients perceived their health to decline by 12% more than their caregivers did over a 1-year period.
Conclusion: PD patients reported decreased HRQoL, with both motor symptoms and NMS negatively impacting HRQoL. Our findings support the routine clinical screening of HRQoL in PD patients to identify and address modifiable factors.

Entities:  

Keywords:  Caregiver; Health care; Health related quality of life; Parkinson’s disease; Quality of life

Year:  2021        PMID: 33423435     DOI: 10.14802/jmd.20079

Source DB:  PubMed          Journal:  J Mov Disord        ISSN: 2005-940X


  10 in total

1.  The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies.

Authors:  Michal Lubomski; Xiangnan Xu; Andrew J Holmes; Samuel Muller; Jean Y H Yang; Ryan L Davis; Carolyn M Sue
Journal:  Front Aging Neurosci       Date:  2022-05-17       Impact factor: 5.702

2.  Nutritional Intake and Gut Microbiome Composition Predict Parkinson's Disease.

Authors:  Michal Lubomski; Xiangnan Xu; Andrew J Holmes; Samuel Muller; Jean Y H Yang; Ryan L Davis; Carolyn M Sue
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

Review 3.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

4.  Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson's Disease I-III H&Y Stage.

Authors:  A A Pilipovich; O V Vorob'eva; S A Makarov; N N Shindryaeva; Yu D Vorob'eva
Journal:  Parkinsons Dis       Date:  2022-04-28

5.  Quantification Analysis of Sleep Based on Smartwatch Sensors for Parkinson's Disease.

Authors:  Yi-Feng Ko; Pei-Hsin Kuo; Ching-Fu Wang; Yu-Jen Chen; Pei-Chi Chuang; Shih-Zhang Li; Bo-Wei Chen; Fu-Chi Yang; Yu-Chun Lo; Yi Yang; Shuan-Chu Vina Ro; Fu-Shan Jaw; Sheng-Huang Lin; You-Yin Chen
Journal:  Biosensors (Basel)       Date:  2022-01-27

6.  Characteristics and quality of life of substance users and their caregivers.

Authors:  Jadranka M Maksimovic; Olivera B Sbutega; Aleksandar D Pavlovic; Hristina D Vlajinac; Ivana I Kavecan; Isidora S Vujcic; Sandra B Grujicic Sipetic
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  [The new Parkinson's disease pain classification system (PD-PCS)].

Authors:  V Mylius; S Perez Lloret; C S Brook; M T Krüger; S Hägele-Link; R Gonzenbach; J Kassubek; S Bohlhalter; J P Lefaucheur; L Timmermann; G Kägi; F Brugger; D Ciampi de Andrade; J C Möller
Journal:  Nervenarzt       Date:  2022-01-28       Impact factor: 1.297

8.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

9.  The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.

Authors:  Michal Lubomski; Xiangnan Xu; Jean Y H Yang; Carolyn M Sue; Ryan L Davis; Andrew J Holmes
Journal:  J Neurol       Date:  2021-06-15       Impact factor: 6.682

10.  Predictive Model of Quality of Life in Patients with Parkinson's Disease.

Authors:  Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Marta Carolina Ruiz-Grao; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.